Topics

"Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients" Drugs and Medication Database

18:17 EST 26th January 2020 | BioPortfolio

Here are the most relevant "Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients" Drugs and Medications that we have found in our database.

More Information about "Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients" on BioPortfolio

We have published hundreds of Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients news stories on BioPortfolio along with dozens of Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients Clinical Trials and PubMed Articles about Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients Companies in our database. You can also find out about relevant Correlation Between Daily Physical Activity and Disability, Fatigue, Cognition and Quality of Life in MS Patients Drugs and Medications on this site too.

Showing "Correlation Between Daily Physical Activity Disability Fatigue Cognition" Drugs and Medications, all 5

Possibly Relevant

Rebif [emd serono, inc.]

These highlights do not include all the information needed to use REBIF safely and effectively. See full prescribing information for REBIF. REBIF (interferon beta-1a), for subcutaneous injectionInitial U.S. Approval: 1996

Teriflunomide [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use TERIFLUNOMIDE TABLETS safely and effectively. See full prescribing information for TERIFLUNOMIDE TABLETS.  TERIFLUNOMIDE tablets, for oral use Initial U.S. Approval: 2012

Tecfidera [biogen inc.]

These highlights do not include all the information needed to use TECFIDERA safely and effectively. See full prescribing information for TECFIDERA.TECFIDERA (dimethyl fumarate) delayed-release capsules, for oral useInitial U.S. Approval: 2013

Tysabri [biogen inc.]

These highlights do not include all the information needed to use TYSABRI safely and effectively. See full prescribing information for TYSABRI.TYSABRI (natalizumab) injection, for intravenous useInitial U.S. Approval: 2004

Avonex [biogen inc.]

These highlights do not include all the information needed to use AVONEX safely and effectively. See full prescribing information for AVONEX.AVONEX (interferon beta-1a) injection, for intramuscular injectionInitial U.S. Approval: 1996



Quick Search